Kymera Therapeutics (KYMR) Other Non-Current Assets (2019 - 2026)

Kymera Therapeutics (KYMR) has 8 years of Other Non-Current Assets data on file, last reported at $5.8 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $5.8 million, changed 0.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.8 million (changed 0.05% YoY), and the FY2025 annual result was $5.8 million, up 197.44% from the prior year.
• Other Non-Current Assets was little changed at $5.8 million in Q1 2026 per KYMR's latest filing, from $5.8 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $6.1 million in Q1 2023 and troughed at $2.0 million in Q4 2024.
• A 5-year average of $4.6 million and a median of $5.8 million in 2025 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets surged 754.19% in 2022, then plunged 66.44% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $6.1 million in 2022, then dropped by 5.2% to $5.8 million in 2023, then sank by 66.44% to $2.0 million in 2024, then soared by 197.44% to $5.8 million in 2025, then grew by 0.17% to $5.8 million in 2026.
• Business Quant data shows KYMR's Other Non-Current Assets at $5.8 million in Q1 2026, $5.8 million in Q4 2025, and $5.8 million in Q3 2025.